Cite
HARVARD Citation
Thompson, G. et al. (2023). Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE): a multicentre, double-blind, double-dummy, randomised phase 3 trial. Lancet. 401 (10370), pp. 49-59. [Online].